High expression of CXC chemokine receptor 6 associates with poor prognosis in patients with clear cell renal cell carcinoma.

[1]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[2]  Y. Nordby,et al.  The prognostic significance of CXCL16 and its receptor C-X-C chemokine receptor 6 in prostate cancer. , 2015, The American journal of pathology.

[3]  B. Ye,et al.  Blockade of CXCR6 reduces invasive potential of gastric cancer cells through inhibition of AKT signaling , 2015, International journal of immunopathology and pharmacology.

[4]  Shailesh Singh,et al.  CXCR6 expression in non-small cell lung carcinoma supports metastatic process via modulating metalloproteinases , 2015, Oncotarget.

[5]  Gang Xiao,et al.  CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms , 2015, Oncotarget.

[6]  Le Xu,et al.  Clinical significance of tumor-derived IL-1β and IL-18 in localized renal cell carcinoma: Associations with recurrence and survival. , 2015, Urologic oncology.

[7]  Hyun-Sook Kim,et al.  CXCL16 and CXCR6 in Ewing sarcoma family tumor. , 2014, Human pathology.

[8]  Jing Zhao,et al.  Chinese a Nti鄄 Cancer a Ssociation , 2013 .

[9]  S. Shariat,et al.  Biomarkers in personalised treatment of renal-cell carcinoma. , 2012, The Lancet. Oncology.

[10]  Xianghuo He,et al.  CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinoma. , 2012, Cancer research.

[11]  Han Yong Choi,et al.  The epidemiology of renal cell carcinoma. , 2011, European urology.

[12]  James L. Sherley,et al.  CXCR6, a Newly Defined Biomarker of Tissue-Specific Stem Cell Asymmetric Self-Renewal, Identifies More Aggressive Human Melanoma Cancer Stem Cells , 2010, PLoS ONE.

[13]  Yan Li,et al.  CXCR6/CXCL16 functions as a regulator in metastasis and progression of cancer. , 2010, Biochimica et biophysica acta.

[14]  C. Compton,et al.  The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.

[15]  J. Gillespie,et al.  The Chemokine CXCL16 and Its Receptor, CXCR6, as Markers and Promoters of Inflammation-Associated Cancers , 2009, PloS one.

[16]  Jialiang Hu,et al.  Chemokine C-X-C motif receptor 6 contributes to cell migration during hypoxia. , 2009, Cancer letters.

[17]  G. Kristiansen,et al.  Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients. , 2009, European journal of cancer.

[18]  Jianhua Wang,et al.  CXCR6 induces prostate cancer progression by the AKT/mammalian target of rapamycin signaling pathway. , 2008, Cancer research.

[19]  J. Van Damme,et al.  The role of CXC chemokines and their receptors in cancer. , 2008, Cancer letters.

[20]  Weibing Zhang,et al.  CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cells , 2008, Cancer science.

[21]  Jianhua Wang,et al.  CXCL16 Functions as a Novel Chemotactic Factor for Prostate Cancer Cells In vitro , 2008, Molecular Cancer Research.

[22]  Chih-Hung Hsu,et al.  Chemokine receptor expression profiles in nasopharyngeal carcinoma and their association with metastasis and radiotherapy , 2006, The Journal of pathology.

[23]  J. Cheville,et al.  Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma , 2003, Cancer.

[24]  R. Figlin,et al.  Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .

[26]  S. Fuhrman,et al.  Prognostic significance of morphologic parameters in renal cell carcinoma , 1982, The American journal of surgical pathology.

[27]  A. Jemal,et al.  Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.